Quantinno Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-61,024
Closed -$2.57M 1036
2023
Q2
$2.57M Buy
61,024
+33,913
+125% +$1.37M 0.15% 165
2023
Q1
$966K Buy
+27,111
New +$984K 0.06% 392
2022
Q4
Sell
-20,856
Closed -$983K 842
2022
Q3
$983K Buy
+20,856
New +$1.35M 0.13% 208
2020
Q4
Sell
-4,479
Closed -$238K 442
2020
Q3
$238K Buy
+4,479
New +$267K 0.16% 326
2020
Q1
Sell
-4,054
Closed -$241K 591
2019
Q4
$241K Buy
+4,054
New +$218K 0.15% 334

Other funds holding SYNH

Quantinno Capital Management's SYNH Position: Q3 2023 in Review

Quantinno Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 61,024 shares — an estimated $2.57M sold.

Quantinno Capital Management first reported a position in SYNH in Q4 2019 and held it in 5 quarters. The position peaked at $2.57M in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Quantinno Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Quantinno Capital Management sold 61,024 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $2.57M.
  • Quantinno Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2019 and held it in 5 quarters.
  • Quantinno Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $2.57M in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Quantinno Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.